Autocrine IL-6 or IL-8 secretion by ovarian cancer cells induces resistance to paclitaxel and cisplatin, due to decreased proteolytic caspase 3 activation, increased Bcl-2 expression, and MAPK and PI3K/Akt pathway activation (71, 72). The gene discussed is IL6; the disease is ovarian cancer.